Wedge Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $626K | Sell |
4,873
-596
| -11% | -$69.8K | 0.01% | 434 |
|
|
2026
Q1 | $658K | Buy |
5,469
+497
| +10% | +$57.4K | 0.01% | 467 |
|
|
2025
Q4 | $523K | Buy |
4,972
+197
| +4% | +$18.5K | 0.01% | 475 |
|
|
2025
Q3 | $401K | Buy |
4,775
+34
| +0.7% | +$2.8K | 0.01% | 493 |
|
|
2025
Q2 | $375K | Buy |
4,741
+272
| +6% | +$21.6K | 0.01% | 479 |
|
|
2025
Q1 | $401K | Buy |
4,469
+70
| +2% | +$6.54K | 0.01% | 479 |
|
|
2024
Q4 | $438K | Hold |
4,399
| – | – | 0.01% | 476 |
|
|
2024
Q3 | $500K | Buy |
4,399
+269
| +7% | +$32K | 0.01% | 463 |
|
|
2024
Q2 | $511K | Buy |
+4,130
| New | +$532K | 0.01% | 450 |
|
|
2023
Q3 | – | Sell |
-4,350
| Closed | -$502K | – | 512 |
|
|
2023
Q2 | $502K | Sell |
4,350
-113
| -3% | -$12.8K | 0.01% | 473 |
|
|
2023
Q1 | $475K | Buy |
4,463
+18
| +0.4% | +$1.94K | 0.01% | 320 |
|
|
2022
Q4 | $493K | Buy |
4,445
+29
| +0.7% | +$2.96K | 0.01% | 315 |
|
|
2022
Q3 | $380K | Sell |
4,416
-105
| -2% | -$9.37K | 0.01% | 326 |
|
|
2022
Q2 | $412K | Sell |
4,521
-111
| -2% | -$9.84K | 0.01% | 325 |
|
|
2022
Q1 | $380K | Sell |
4,632
-138
| -3% | -$10.9K | 0.01% | 334 |
|
|
2021
Q4 | $366K | Buy |
4,770
+61
| +1% | +$4.86K | ﹤0.01% | 341 |
|
|
2021
Q3 | $354K | Buy |
4,709
+25
| +0.5% | +$1.9K | ﹤0.01% | 338 |
|
|
2021
Q2 | $364K | Sell |
4,684
-1,336
| -22% | -$99.4K | ﹤0.01% | 328 |
|
|
2021
Q1 | $443K | Sell |
6,020
-233
| -4% | -$17.2K | 0.01% | 381 |
|
|
2020
Q4 | $488K | Buy |
6,253
+202
| +3% | +$15.4K | 0.01% | 401 |
|
|
2020
Q3 | $479K | Buy |
6,051
+220
| +4% | +$17.2K | 0.01% | 381 |
|
|
2020
Q2 | $430K | Buy |
5,831
+45
| +0.8% | +$3.39K | 0.01% | 371 |
|
|
2020
Q1 | $425K | Hold |
5,786
| – | – | 0.01% | 358 |
|
|
2019
Q4 | $502K | Buy |
5,786
+184
| +3% | +$15.1K | 0.01% | 396 |
|
|
2019
Q3 | $450K | Hold |
5,602
| – | – | 0.01% | 418 |
|
|
2019
Q2 | $448K | Buy |
5,602
+1,686
| +43% | +$129K | 0.01% | 472 |
|
|
2019
Q1 | $311K | Sell |
3,916
-451,228
| -99% | -$33.7M | ﹤0.01% | 519 |
|
|
2018
Q4 | $33.2M | Sell |
455,144
-63,442
| -12% | -$4.48M | 0.41% | 80 |
|
|
2018
Q3 | $35.1M | Sell |
518,586
-7,490
| -1% | -$477K | 0.34% | 90 |
|
|
2018
Q2 | $30.5M | Sell |
526,076
-125,036
| -19% | -$7.05M | 0.3% | 106 |
|
|
2018
Q1 | $33.8M | Sell |
651,112
-202,037
| -24% | -$10.9M | 0.32% | 93 |
|
|
2017
Q4 | $45.8M | Buy |
853,149
+220,886
| +35% | +$12.2M | 0.41% | 66 |
|
|
2017
Q3 | $38.6M | Buy |
632,263
+8,318
| +1% | +$504K | 0.36% | 85 |
|
|
2017
Q2 | $38.2M | Sell |
623,945
-119,933
| -16% | -$7.3M | 0.37% | 82 |
|
|
2017
Q1 | $45.1M | Sell |
743,878
-157,237
| -17% | -$9.54M | 0.43% | 81 |
|
|
2016
Q4 | $50.6M | Buy |
901,115
+24,548
| +3% | +$1.44M | 0.49% | 60 |
|
|
2016
Q3 | $52.2M | Sell |
876,567
-22,964
| -3% | -$1.34M | 0.52% | 50 |
|
|
2016
Q2 | $49.4M | Buy |
899,531
+94,267
| +12% | +$5.02M | 0.51% | 54 |
|
|
2016
Q1 | $40.7M | Buy |
805,264
+50,940
| +7% | +$2.49M | 0.42% | 62 |
|
|
2015
Q4 | $38M | Sell |
754,324
-4,847
| -0.6% | -$244K | 0.4% | 84 |
|
|
2015
Q3 | $35.8M | Sell |
759,171
-18,366
| -2% | -$976K | 0.38% | 85 |
|
|
2015
Q2 | $42.2M | Buy |
+777,537
| New | +$43.6M | 0.41% | 88 |
|
|
2013
Q4 | – | Sell |
-837,153
| Closed | -$38M | – | 504 |
|
|
2013
Q3 | $38M | Buy |
837,153
+29,737
| +4% | +$1.36M | 0.44% | 83 |
|
|
2013
Q2 | $35.8M | Buy |
+807,416
| New | +$36.1M | 0.43% | 82 |
|
Other funds holding MRK
LMFP
ATO
QP
Wedge Capital Management's MRK Position: Q2 2026 in Review
Wedge Capital Management reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $69.8K and leaving 4,873 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #434.
Wedge Capital Management first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $52.2M in Q3 2016. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Wedge Capital Management held 4,873 shares of Merck worth $626K as of Q2 2026.
- Wedge Capital Management sold 596 Merck shares in Q2 2026, an estimated $69.8K.
- Merck made up 0.01% of Wedge Capital Management's portfolio in Q2 2026, its #434 holding.
- Wedge Capital Management first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
- Wedge Capital Management's Merck position peaked at $52.2M in Q3 2016.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.